TRPV2 and hepatocellular carcinoma: CBD enhances the action of doxorubicin in hepatocellular carcinoma by promoting doxorubicin entry into cancer cells through TRPV2 and inhibiting P-glycoprotein ATPase transporter to reduce doxorubicin clearance [11].